Abbott faces more lawsuits over faulty diagnostic tests
This article was originally published in Clinica
Executive Summary
Abbott Laboratories is facing four further lawsuits from women who claim that false positive results from the B-hCG, or human chorionic gonadatropin, pregnancy test kit on Abbott's AxSYM platform, led to unnecessary cancer treatments, including chemotherapy and a hysterectomy.